Ona Therapeutics hits the road thanks to Sabadell Asabys Blog Post

Today Ona Therapeutics, the new IRB Barcelona spin-off, announced the close of a seed funding round of € 1.5M given by Sabadell Asabys, a fund managed by Asabys Partners and devoted to investments in health innovation. With this injection of capital, the company, based in the Barcelona Science Park, will begin work on the development of a new drug for the treatment of metastatic cancer.

 

ODISSeA: a pioneer initiative to improve organ donation in Southeast Asian countries Blog Post

Promoting highly specialized training for experts in the field of organ donation in Southeast Asian countries is the main aim of the training program Train the trainers, to take place from May 13 to 17 in Barcelona, under the direction of Martí Manyalich, lecturer at the Faculty of Medicine and Health Sciences of the UB and president of the DTI Foundation – Donation & Transplantation Institute, located in the Barcelona Science Park. This training initiative for physicians is part of the ODISSeA project and will finish with an institutional ceremony to take place in the Aula Magna at the Faculty of Medicine and Health Sciences of the UB on Friday, May 17.

 

The Barcelona Science Park launches the 15th edition of BATX2LAB Blog Post

The Barcelona Science Park has just opened the registration for the 15th edition of BATX2LAB, which offers High School students the chance to carry out the practical part of their research project in the PCB laboratories under the tutorship of a scientist. This initiative is part of PCB’s Research in Society programme –a proposal to bring science to citizens and promote research careers in young student– that offers over 100 activities in which around 5,000 people participate every year.

 

Two UB centers create a new platform on neurotoxicology and drug testing based on stem cells Blog Post

The Production and Validation Center for Advanced Therapies (Creatio) and the Research Centre on Toxicology (CERETOX) –through the Unit of Experimental Toxicology and Ecotoxicology (UTOX) from the Barcelona Science Park (PCB–, entities of the University of Barcelona with the Tecnio seal, have created the platform Avantdrug. The new platform offers services to companies and research groups to carry out drug neurotoxicity tests and drug screenings in vitro using neurons taken from pluripotent stem cells (HPSC).

 

OilFlux opens a R&D&i center at the Barcelona Science Park Blog Post

OilFlux, specialized in the development of technology that increases the efficiency of processes within the crude oil industry, has opened a R&D&i centre at the Barcelona Science Park. The objective of the company –which develops, manufactures and distributes its products to countries across all five continents– is to increase the quality of the ongoing research and development (R&D) of its formulations to resolve the problems associated with the crude oil and natural gas extraction processes and to reduce the environmental impact as well.

 

Characterisation of the structure and function of a member of the L-Amino acid Transporter (LAT) family Blog Post

Scientists at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park and the CIBER of Rare Diseases (CIBERER) – in collaboration with the Institute of Molecular Biology of Barcelona (IBMB-CSIC) at PCB, and the Barcelona Supercomputing Center-Centro Nacional de Supercomputación (BSC-CNS) – have now characterised the structure of a member of the LAT family. Mutations in L-amino acid transporters (LATs) can lead to a wide range of conditions, such as autism, hearing loss and aminoacidurias. The work has been published in the journal Nature Communications.

 

Moldless approach to generate 3D intestinal tissue model using hydrogels Blog Post

The Biomimetic systems for cell engineering group, lead by Elena Martínez at IInstitute for Bioengineering of Catalonia (IBEC), has developed a new method to generate 3D intestinal tissue using hydrogels. This new in vitro model has been improved by providing cells with a more physiologically realistic environment, including tissue architecture, cell-matrix interactions and chemical signalling while remaining compatible with standard cell characterization techniques.

 

World’s first baby is born in Greece through of Maternal Spindle Transfer technique developed by Embryotools Blog Post

Through pioneering clinical research, Embryotools, based in the Barcelona Science Park, and Institute of Life in Athens have achieveg birth of the world’s first healthy baby through the pioneering Maternal Spindle Transfer method to solve infertility problems. This technique was implemented by the Greek IVF center and Spanish research center to address fertility issues associated with multiple in vitro fertilization (IVF) failures caused by cytoplasmic dysfunction of the oocytes or rare mitochondrial genetic diseases.

 

Dr. Cristina Bescos is new Managing Director of EIT Health Spain Blog Post

Dr. Cristina Bescos has been named the new Managing Director of EIT Health Spain, based in the Barcelona Science Park. She began her work 8 April 2019, after being approved by the EIT Health Spain Board to take over the position that had been held by Dr. Marco Pugliese since its creation in 2016. Her expertise and knowledge will continue to foster the main strategic areas covered by the partners of the Spanish node of EIT Health, the Knowledge and Innovation Community (KIC), dedicated to healthy living and active aging, promoted by the European Institute of Technology and Innovation (EIT).